Breastfeeding After IV Ketamine
She can resume breastfeeding as soon as she has recovered from the procedure and feels alert enough to safely hold her infant—no waiting period is required. 1
Key Recommendation
The 2020 Association of Anaesthetists guideline explicitly states that while no data are available on ketamine transfer into human milk, levels are likely to be low due to rapid redistribution from plasma, making adverse effects in the infant unlikely 1. The guideline lists ketamine among anesthetic agents compatible with breastfeeding and notes that small amounts of intravenous anesthetic agents remaining in body fat stores for 24-48 hours do not preclude resumption of normal breastfeeding 1.
Supporting Evidence from Recent Research
Two high-quality 2023 pharmacokinetic studies provide reassuring data:
- Relative infant dose (RID) for ketamine ranged from 0.34% to 0.77% across different dosing regimens 2, 3
- Both ketamine and its active metabolite norketamine showed RIDs well below 1%—far beneath the standard 10% safety threshold 3
- Levels in breast milk were low and rapidly declining during the 12-hour post-dosing period 2
- No infant adverse effects were reported in any of the studies 3
A 2021 study of 298 breastfed neonates whose mothers received ketamine (up to 3.8 mg/kg) for postpartum tubal ligation found no severe outcomes, with 98% of neonates breastfeeding well on the first postoperative day 4.
Clinical Guidance
When to resume:
- As soon as the mother is awake, alert, and physically capable of holding her infant safely 1, 5
- The primary concern is maternal sedation affecting her ability to care for the infant, not drug transfer through milk
Monitoring considerations:
- Advise the mother to observe the infant for signs of drowsiness and poor feeding 1
- If these signs occur, she should contact a medical professional
- However, given ketamine's rapid redistribution (half-life 10-15 minutes for the alpha phase, 2.5 hours for beta phase) 6, clinically significant effects are unlikely
Important Caveats
Co-sleeping precaution: If the mother normally co-sleeps with her infant, she should take precautions immediately post-procedure as her natural responsiveness may be temporarily inhibited 1. This is a safety concern related to maternal sedation, not drug transfer.
Preferential agent selection: The guideline notes that other induction agents should be used if possible, though this reflects the lack of human milk transfer data rather than evidence of harm 1.